Similarly, the exact same trend in the above factors could be reproduced in the femur bone marrow (Fig. 4A–E), further confirming that LP45 exhibited anti-osteoporosis effect in the pathological setting of GIO, which was mediated by the RANKL/OPG pathway. The gene discussed is TNFRSF11B; the disease is osteoporosis.